AstraZeneca has been busy in recent years pumping up its oncology pipeline via a shopping list of assets and companies. | ...

The pharmaceutical ... toward precision medicine – choosing the right therapy for a patient based on molecular understanding of their disease – and less on traditional cancer therapies such ...

The high-stakes nature of cancer care, coupled with rapid scientific advancements and increasing payer and regulatory ...

Based on Intelligencia AI’s comprehensive, proprietary database of over 20,000 industry-sponsored, interventional oncology clinical programs (around 12,400 clinical trials), recent insights highlight ...

A University of Iowa-led study has revealed the unexpected structure adopted by the DNA repair protein RAD52 as it binds and protects replicating DNA in dividing cells. This new structural and ...

AstraZeneca has secured another expansion of its Imfinzi for use in cancer patients before and after surgery. | Imfinzi is ...

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...

Takeda is sharpening its oncology focus amid ... Hong Kong-based Insilico Medicine has raised $110 million to advance its artificial-intelligence-powered drug design platforms.